nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Altered EZH2 splicing and expression is associated with impaired histone H3 lysine 27 tri-Methylation in myelodysplastic syndrome
|
Shirahata-Adachi, Mizuho |
|
2017 |
63 |
C |
p. 90-97 |
artikel |
2 |
Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS Group
|
Nomdedeu, Meritxell |
|
2017 |
63 |
C |
p. 85-89 |
artikel |
3 |
DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia
|
Ozdogan, Hakan |
|
2017 |
63 |
C |
p. 62-71 |
artikel |
4 |
Differential T cell subsets and cytokine profile between steady-state and G-CSF-primed bone marrow and its association with graft-versus-host disease
|
León-Rodríguez, Eucario |
|
2017 |
63 |
C |
p. 47-52 |
artikel |
5 |
Distinct EphB4-mediated mechanisms of apoptotic and resistance to dasatinib in human chronic myeloid leukemia and K562 cell lines
|
Zhao, Wei-Hong |
|
2017 |
63 |
C |
p. 28-33 |
artikel |
6 |
Editorial board and publication information
|
|
|
2017 |
63 |
C |
p. IFC |
artikel |
7 |
Frondoside A potentiates the effects of conventional therapeutic agents in acute leukemia
|
Sajwani, F.H. |
|
2017 |
63 |
C |
p. 98-108 |
artikel |
8 |
High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission
|
Candoni, Anna |
|
2017 |
63 |
C |
p. 22-27 |
artikel |
9 |
Impact of baseline cytogenetic findings and cytogenetic response on outcome of high-risk myelodysplastic syndromes and low blast count AML treated with azacitidine
|
Sébert, Marie |
|
2017 |
63 |
C |
p. 72-77 |
artikel |
10 |
In vitro studies on the role of recombinant human soluble thrombomodulin in the context of retinoic acid mediated APL differentiation syndrome
|
Kojima, Shinsuke |
|
2017 |
63 |
C |
p. 1-9 |
artikel |
11 |
JAK2V617F detection and allele burden measurement in saliva vs. peripheral blood in patients with myelofibrosis
|
Strati, Paolo |
|
2017 |
63 |
C |
p. 53-55 |
artikel |
12 |
Nucleostemin silencing induces differentiation and potentiates all-trans-retinoic acid effects in human acute promyelocytic leukemia NB4 cells via autophagy
|
Fakhimahmadi, Aila |
|
2017 |
63 |
C |
p. 15-21 |
artikel |
13 |
Predictors for requiring re-induction chemotherapy in acute myeloid leukemia patients with residual disease on day 14 bone marrow assessment
|
Nachar, Victoria R. |
|
2017 |
63 |
C |
p. 56-61 |
artikel |
14 |
Relationship between lenalidomide dose modification, duration of therapy, and long-term outcomes in patients with myelodysplastic syndromes
|
DeZern, Amy E. |
|
2017 |
63 |
C |
p. 10-14 |
artikel |
15 |
Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needs
|
Scotch, Allison H. |
|
2017 |
63 |
C |
p. 34-40 |
artikel |
16 |
Therapeutic options for leukemic transformation in patients with myeloproliferative neoplasms
|
Khan, Maliha |
|
2017 |
63 |
C |
p. 78-84 |
artikel |
17 |
Towards repositioning of quinacrine for treatment of acute myeloid leukemia – Promising synergies and in vivo effects
|
Eriksson, Anna |
|
2017 |
63 |
C |
p. 41-46 |
artikel |